Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Saiyun Lei & Lei Xiang. (2020) Up-Regulation of circRNA hsa_circ_0003074 Expression is a Reliable Diagnostic and Prognostic Biomarker in Patients with Osteosarcoma. Cancer Management and Research 12, pages 9315-9325.
Read now
Read now
Weilu Gao, Yong Hu, Zhengqin Zhang, Gongwen Du, Li Yin & Zongsheng Yin. (2019) Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CASP3/7 and Chk1/2 by upregulating SAPK/JNK. OncoTargets and Therapy 12, pages 1225-1235.
Read now
Read now
Bo Qiao, Wei Shui, Li Cai, Shuquan Guo & Dianming Jiang. (2015) Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. Drug Design, Development and Therapy 9, pages 969-976.
Read now
Read now
Ninna Aggerholm-Pedersen, Katja Maretty-Nielsen, Johnny Keller, Steen Baerentzen, Henrik Schrøder, Peter Holmberg Jørgensen, Bjarne Hauge Hansen, Ole Steen Nielsen & Akmal Safwat. (2015) The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database. Acta Oncologica 54:1, pages 17-24.
Read now
Read now
Kjetil Berner, Tom Børge Johannesen, Aasmund Berner, Hans Kristian Haugland, Bodil Bjerkehagen, Per J. Bøhler & Øyvind S. Bruland. (2015) Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncologica 54:1, pages 25-33.
Read now
Read now
Articles from other publishers (52)
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, Rasoul Raesi, Alireza Bahonar, Zahra Nakhaee, Maliheh Entezari, Mohammad Ali Sheikh Beig Goharrizi, Shokooh Salimimoghadam, Jun Ren, Noushin Nabavi, Mohsen Rashidi, Farshid Dehkhoda, Afshin Taheriazam, Shing Cheng Tan & Kiavash Hushmandi. (2023) New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis. Pathology - Research and Practice 251, pages 154902.
Crossref
Crossref
Yao Jiang & Ke He. (2023) Nanobiotechnological approaches in osteosarcoma therapy: Versatile (nano)platforms for theranostic applications. Environmental Research 229, pages 115939.
Crossref
Crossref
Boyu Pan, Xiaoyun Cheng, Wei Tan, Renfeng Liu, Xin Wu, Jinpeng He, Qizhi Fan, Yan Zhang, Jun Cheng & Youwen Deng. (2023) Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma. Frontiers in Immunology 14.
Crossref
Crossref
Badria Alkazemi, Feras M. Ghazawi, François Lagacé, Vladimir Nechaev, Andrei Zubarev & Ivan V. Litvinov. (2023) Investigation of the Incidence and Geographic Distribution of Bone and Soft Tissue Sarcomas in Canada: A National Population-Based Study. Current Oncology 30:6, pages 5631-5651.
Crossref
Crossref
Shengwen Cheng, Senrui Liu, Bowen Chen, Chengcheng Du, Pengcheng Xiao, Xuefeng Luo, Li Wei, Yiting Lei, Chen Zhao & Wei Huang. (2023) Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways. Chinese Medicine 18:1.
Crossref
Crossref
Parnia Rahnamay Farnood, Romina Danesh Pazhooh, Zatollah Asemi & Bahman Yousefi. (2023) Targeting Signaling Pathway by Curcumin in Osteosarcoma. Current Molecular Pharmacology 16:1, pages 71-82.
Crossref
Crossref
Chien-Feng Huang, Yi-Hsien Hsieh, Shun-Fa Yang, Chao-Hung Kuo, Pei-Han Wang, Chung-Jung Liu & Renn-Chia Lin. (2023) Mitophagy Effects of Protodioscin on Human Osteosarcoma Cells by Inhibition of p38MAPK Targeting NIX/LC3 Axis. Cells 12:3, pages 395.
Crossref
Crossref
Yingnan Wu, Zhenzhen Wang, Shan Yu, Dongzhe Liu & Litao Sun. (2022) LncmiRHG-MIR100HG: A new budding star in cancer. Frontiers in Oncology 12.
Crossref
Crossref
Weilin Wang, Jianhua Wang, Yingyi Li & Yongxu Zhao. (2022) Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner. Journal of Bone Oncology 35, pages 100436.
Crossref
Crossref
Yuxiang Kang, Guowang Li, Guohua Wang, Zhenxin Huo, Xiangling Feng, Lilong Du, Yongjin Li, Qiang Yang, Xinlong Ma, Bingbing Yu & Baoshan Xu. (2022) Development of a Risk Score Model for Osteosarcoma Based on DNA Methylation-Driven Differentially Expressed Genes. Journal of Oncology 2022, pages 1-9.
Crossref
Crossref
Juncheng Cui, Dylan Dean, Francis J Hornicek, Guoliang Yi & Zhenfeng Duan. (2022)
Expression and Clinical Significance of High‐Mobility Group
AT‐hook 2
(
HMGA2
) in Osteosarcoma
. Orthopaedic Surgery 14:5, pages 955-966.
Crossref
Crossref
Weihang Li, Ziyi Ding, Dong Wang, Chengfei Li, Yikai Pan, Yingjing Zhao, Hongzhe Zhao, Tianxing Lu, Rui Xu, Shilei Zhang, Bin Yuan, Yunlong Zhao, Yanjiang Yin, Yuan Gao, Jing Li & Ming Yan. (2021) Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9. Cancer Cell International 21:1.
Crossref
Crossref
George N. Tzanakakis, Eirini-Maria Giatagana, Aikaterini Berdiaki, Ioanna Spyridaki, Kyoko Hida, Monica Neagu, Aristidis M. Tsatsakis & Dragana Nikitovic. (2021) The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis. Cancers 13:10, pages 2478.
Crossref
Crossref
Xue-Feng Li, Guo-Qing Zhao & Long-Yun Li. (2021) Ginsenoside impedes proliferation and induces apoptosis of human osteosarcoma cells by down-regulating β-catenin1. Cancer Biomarkers 24:4, pages 395-404.
Crossref
Crossref
Xiao-Yu Xie, Xian-Ming Chen, Ling Shi & Jun-Wei Liu. (2021) Increased expression of microRNA-26a-5p predicted a poor survival outcome in osteosarcoma patients. Medicine 100:12, pages e24765.
Crossref
Crossref
Yi-Hsien Hsieh, Wen-Hung Hsu, Shun-Fa Yang, Chung-Jung Liu, Ko-Hsiu Lu, Pei-Han Wang & Renn-Chia Lin. (2021) Potential Antimetastatic Effect of Timosaponin AIII against Human Osteosarcoma Cells through Regulating the Integrin/FAK/Cofilin Axis. Pharmaceuticals 14:3, pages 260.
Crossref
Crossref
Xin Zhao, Qirui Wu, Xiuqing Gong, Jinfeng Liu & Yujie Ma. (2021) Osteosarcoma: a review of current and future therapeutic approaches. BioMedical Engineering OnLine 20:1.
Crossref
Crossref
Wazzan S. Aljuhani, Abdullah M. Alanazi & Mohammad A. Alghafees. (2021) Primary bone sarcomas in KSA: A Saudi tumor registry review. Journal of Taibah University Medical Sciences 16:1, pages 77-85.
Crossref
Crossref
Dewei Shen, Yize Liu, Yuexin Liu, Tao Wang, Lin Yuan, Xuyang Huang & Yong Wang. (2020) Long non‐coding RNA EWSAT1 promoted metastasis and actin cytoskeleton changes via miR‐24‐3p sponging in osteosarcoma. Journal of Cellular and Molecular Medicine 25:2, pages 716-728.
Crossref
Crossref
Cheng‐Qun Wang, Xiu‐Mei Wang, Bing‐Liang Li, Yuan‐Min Zhang & Lei Wang. (2020)
Arbutin suppresses osteosarcoma progression via
miR‐338‐3p
/MTHFD1L and inactivation of the AKT/mTOR pathway
. FEBS Open Bio 11:1, pages 289-299.
Crossref
Crossref
Juncheng Cui, Dylan Dean, Francis J. Hornicek, Zhiwei Chen & Zhenfeng Duan. (2020) The role of extracelluar matrix in osteosarcoma progression and metastasis. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Shuai Ding, Guangquan Zhang, Yanzheng Gao, Shulian Chen & Chen Cao. (2020) Circular RNA hsa_circ_0005909 modulates osteosarcoma progression via the miR-936/HMGB1 axis. Cancer Cell International 20:1.
Crossref
Crossref
Naiqiang Zhu, Jingyi Hou, Guiyun Ma, Shuai Guo, Chengliang Zhao & Bin Chen. (2020) Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma. Cancer Cell International 20:1.
Crossref
Crossref
Chenchen Li, Huan Gao, Xuemei Feng, Chuyao Bi, Jing Zhang & Jianyuan Yin. (2020) Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF‐κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells. Journal of Biochemical and Molecular Toxicology 34:12.
Crossref
Crossref
Juncheng Cui, Dylan Dean, Ran Wei, Francis J. Hornicek, David Ulmert & Zhenfeng Duan. (2020) Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma. Journal of Orthopaedic Research 38:11, pages 2362-2372.
Crossref
Crossref
Haoli Jiang, Wei Guo, Shanyou Yuan & Lixia Song. (2020) PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma. BioMed Research International 2020, pages 1-12.
Crossref
Crossref
SherlyDesnita Savio, MariaFlorencia Deslivia, Putu Astawa & IGede Eka Wiratnaya. (2020) The outcome comparison of limb salvage surgery versus amputation for high-grade osteosarcoma: A systematic review and meta-analysis of the last 7-year studies. Journal of Orthopedics, Traumatology and Rehabilitation 12:1, pages 67.
Crossref
Crossref
Blaž Mavčič, Marko Špiler & David Martinčič. (2019) Oncological and endoprosthetic outcomes of bone sarcoma patients: a nationwide cohort study. European Journal of Orthopaedic Surgery & Traumatology 30:1, pages 31-35.
Crossref
Crossref
R. Kontio, J. Hagström, P. Lindholm, T. Böhling, M. Sampo, K. Mesimäki, K. Saarilahti, P. Koivunen & A.A. Mäkitie. (2019) Craniomaxillofacial osteosarcoma — The role of surgical margins. Journal of Cranio-Maxillofacial Surgery 47:6, pages 922-925.
Crossref
Crossref
Bing Wang, Xing‐Long Qu, Jiaxiang Liu, Junhui Lu & Zong‐Yu Zhou. (2018) HOTAIR promotes osteosarcoma development by sponging miR‐217 and targeting ZEB1. Journal of Cellular Physiology 234:5, pages 6173-6181.
Crossref
Crossref
Zhou Dong & Yun Wang. (2019) LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3. Pathology - Research and Practice 215:3, pages 571-579.
Crossref
Crossref
Weidong Zhao & Li Li. (2019) SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma. Pathology - Research and Practice 215:3, pages 439-445.
Crossref
Crossref
Xiaochuan Su, Junyan Teng, Guoguo Jin, Jitian Li, Zhenjiang Zhao, Xiangyang Cao, Yanxing Guo, Malong Guo, Xiaoling Li, Jun Wu, Chuanzhen Wang, Zhiping Guo & Qing Guo. (2019) ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2. Biomedicine & Pharmacotherapy 109, pages 788-797.
Crossref
Crossref
Yong Wang, Xiandong Zeng, Ningning Wang, Wei Zhao, Xi Zhang, Songling Teng, Yueyan Zhang & Zhi Lu. (2018) Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. Molecular Cancer 17:1.
Crossref
Crossref
Zhengfeng Xu, Jiajun Wu, Pan Cai, Xiaoxiao Zhou, Cunguo Yi & Bin Wang. (2018) Effects of FHIT gene on proliferation and apoptosis of osteosarcoma cells. Oncology Letters.
Crossref
Crossref
Kjetil Berner, Olga Zaikova, Tom Børge Johannesen, Kirsten Sundby Hall & Øyvind S. Bruland. (2018) Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway. Journal of Surgical Oncology 118:1, pages 246-247.
Crossref
Crossref
James Coventon. (2017) A review of the mechanism of action and clinical applications of sorafenib in advanced osteosarcoma. Journal of Bone Oncology 8, pages 4-7.
Crossref
Crossref
Chuanzhen Hu, Xu Chen, Junxiang Wen, Liangzhi Gong, Zhuochao Liu, Jun Wang, Jing Liang, Fangqiong Hu, Qi Zhou, Li Wei, Yuhui Shen & Weibin Zhang. (2017)
Antitumor effect of focal adhesion kinase inhibitor PF562271 against human osteosarcoma
in vitro
and
in vivo
. Cancer Science 108:7, pages 1347-1356.
Crossref
Crossref
Zhi-Cai Zhang, Jian-Xiang Liu, Zeng-Wu Shao, Fei-Fei Pu, Bai-Chuan Wang, Qiang Wu, Yu-Kun Zhang, Xian-Lin Zeng, Xiao-Dong Guo, Shu-Hua Yang & Tong-Chuan He. (2017) In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma. Medicine 96:27, pages e7245.
Crossref
Crossref
Yong Wang, Tao Yang, Zhen Zhang, Ming Lu, Wei Zhao, Xiandong Zeng & Weiguo Zhang. (2017)
Long non‐coding
RNA TUG
1 promotes migration and invasion by acting as a ce
RNA
of miR‐335‐5p in osteosarcoma cells
. Cancer Science 108:5, pages 859-867.
Crossref
Crossref
Xiaolong Yu, Qiang Wang, Xin Zhou, Changlin Fu, Ming Cheng, Runsheng Guo, Hucheng Liu, Bin Zhang & Min Dai. (2016) Celastrol negatively regulates cell invasion and migration ability of human osteosarcoma via downregulation of the PI3K/Akt/NF-κB signaling pathway in vitro. Oncology Letters 12:5, pages 3423-3428.
Crossref
Crossref
Quan Zhou, Fengli Chen, Zhongting Fei, Jiali Zhao, Yong Liang, Wei Pan, Xingxiang Liu & Donghui Zheng. (2016) Genetic variants of lncRNA HOTAIR contribute to the risk of osteosarcoma. Oncotarget 7:15, pages 19928-19934.
Crossref
Crossref
Olga Zaikova, Kirsten Sundby Hall, Emelie Styring, Mikael Eriksson, Clement S. Trovik, Peter Bergh, Bodil Bjerkehagen, Mikael Skorpil, Harald Weedon-Fekjaer & Henrik C.F. Bauer. (2015) Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia-SSG Central Register 25 years' experience. Journal of Surgical Oncology 112:8, pages 853-860.
Crossref
Crossref
Ke Ren, Xiao Lu, Nan Yao, Yong Chen, Aizhen Yang, Hui Chen, Jian Zhang, Sujia Wu, Xin Shi, Chen Wang & Xiaoliang Sun. (2015) Focal adhesion kinase overexpression and its impact on human osteosarcoma. Oncotarget 6:31, pages 31085-31103.
Crossref
Crossref
Joni Serlo, Maija Tarkkanen, Mika Sampo, Kim Vettenranta, Pekka Riikonen & Ilkka Helenius. (2015) Incidence, treatment and survival of paediatric patients with bone sarcomas in Finland from 1991 to 2005. Acta Paediatrica 104:7, pages 738-745.
Crossref
Crossref
Kjetil Berner, Tom Børge Johannesen & Øyvind S. Bruland. (2015) Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009. Sarcoma 2015, pages 1-9.
Crossref
Crossref
Kjetil Berner, Kirsten Sundby Hall, Odd R. Monge, Harald Weedon-Fekjær, Olga Zaikova & Øyvind S. Bruland. (2015) Prognostic Factors and Treatment Results of High-Grade Osteosarcoma in Norway: A Scope Beyond the “Classical” Patient. Sarcoma 2015, pages 1-14.
Crossref
Crossref
I. Kushnir, Y. Kolander, J. Bickels, Y. Gortzak, G. Flusser, J. Issakov & O. Merimsky. (2014) Is it important to maintain high-dose intensity chemotherapy in the treatment of adults with osteosarcoma?. Medical Oncology 31:5.
Crossref
Crossref
N.O. Basta, P.W. James, B. Gomez-Pozo, A.W. Craft, P. Norman & R.J.Q. McNally. (2014) Survival from teenage and young adult cancer in Northern England, 1968-2008. Pediatric Blood & Cancer 61:5, pages 901-906.
Crossref
Crossref
Mehmet Metin Seker, Ayse Seker, Sercan Aksoy, Nuriye Ozdemir, Dogan Uncu & Nurullah Zengin. (2014) Clinicopathologic Features and Prognosis of Osteosarcoma in Turkish Adults. Asian Pacific Journal of Cancer Prevention 15:8, pages 3537-3540.
Crossref
Crossref
Patrick W. O’Donnell, Anthony M. Griffin, William C. Eward, Amir Sternheim, Jay S. Wunder & Peter C. Ferguson. (2013) Early follow-up of a custom non-fluted diaphyseal press-fit tumour prosthesis. International Orthopaedics 38:1, pages 123-127.
Crossref
Crossref
Rozalia Dimitriou, George I Mataliotakis, Giorgio Maria Calori & Peter V Giannoudis. (2012) The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence. BMC Medicine 10:1.
Crossref
Crossref